Aegon Ltd. vs Ginkgo Bioworks Holdings Inc — how do they compare? Aegon Ltd. trades at $9.45 (market cap $14.01B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Aegon Ltd. is far larger — about 27.7× Ginkgo Bioworks Holdings Inc's market cap, and Aegon Ltd. pays a 4.94% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| AEG | DNA | |
|---|---|---|
Market Cap | $14.01B | $505.73M |
Sector | Financials | Health |
52-Week High | $9.53 | $16.14 |
52-Week Low | $6.79 | $5.48 |
Enterprise Value | $15.16B | $607.68M |
Dividend Yield | 4.94% | — |
Trailing returns across standard periods
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →